KalVista Pharmaceuticals Inc (NASDAQ:KALV) - Share price


Stock Report

KalVista Pharmaceuticals Inc KALV

Last Price
$9.90

Day Change
0.06|0.61%

As of 01/07/2022
16:02:34 EDT | USD
Minimum 15 Minutes Delay.

Last Close9.84
Day Range9.50 - 10.08
Mkt Cap243.00Mil
52-Wk Range8.00 - 24.80
Yield %-
ISINUS4834971032
Volume104,803
P/E-
P/S
P/CF-3.81

Share Price

Financials
201920202021
More ...
Income Statement
Revenue16.1312.690.00
Operating Income-29.82-40.53-57.92
Net Income-20.82-29.12-46.24
Basic EPS-1.38-1.64-2.42
Avg. Diluted Shares Outstanding151819
Balance Sheet
Current Assets115.5588.70264.26
Non Current Assets2.593.837.75
Total Assets118.1392.53272.01
Current Liabilities18.057.729.77
Total Liabilities---
Total Equity96.7483.75257.19
Cash Flow
Operating Cash Flow-36.37-44.82-30.17
Capital Expenditure-1.08-0.22-0.08
Free Cash Flow-37.45-45.04-30.25

In millions, except "Basic EPS". Currency is USD.

Company Profile

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates through the region of the United States.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

April

Employees

70
Key Stats
More ...
Price/Earning TTM-3.23
Price/Book1.16
Price/Sales TTM
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-∞
Net Margin % TTM-∞
ROE TTM-27.13
Debt/Equity0.02
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.